陕西麦科奥特科技有限公司
麦科奥特成立于2007年，是一群以“挽救生命、减轻病痛”为使命、以”创制一线抢救和治疗药物，满足未被满足的临床需求“为己任的海归科学家创办的。誓做全球创新多肽药物研发者，多肽新药细分领域世界No.1，心血管创新药物中国No.1。
China
11 employees
Series C
Total: $575.00M
Health Care
General Information
China
BounceWatch is an independent company data service, not affiliated with 陕西麦科奥特科技有限公司. To contact 陕西麦科奥特科技有限公司, visit micot.cn.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does 陕西麦科奥特科技有限公司 compare?
A PDF of 陕西麦科奥特科技有限公司 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting 陕西麦科奥特科技有限公司 soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
China Market
Health Care
About 陕西麦科奥特科技有限公司
Taxonomy: pharmaceuticals, biopharmaceuticals, drug development, peptide drugs, innovation, clinical research, biomedical technology, cardiovascular diseases, neurological diseases, biomedical research, biomedical delivery systems, metabolic diseases, global operations, biomedical production
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | CNY100.00M | 1 |
|
10 Feb 2023 |
| Series B | CNY360.00M | 3 |
|
22 Jun 2021 |
| Seed Round | CNY115.00M | 3 |
|
16 Oct 2019 |
陕西麦科奥特科技有限公司 Alternatives & Competitors
View All Alternatives
Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduced side-ef...
Pioneering a novel drug platform to safeguard and rejuvenate mitochondrial health in degenerative di...
Turning promising peptides into groundbreaking therapeutics for chronic diseases
FAQ About 陕西麦科奥特科技有限公司
Source: BounceWatch company record for 陕西麦科奥特科技有限公司, https://bouncewatch.com/company/-1811, updated 30 December 2024. When citing, please name BounceWatch and link this page.
